Jasbir Seehra
Chief Executive Officer bij KEROS THERAPEUTICS, INC.
Vermogen: 17 M $ op 29-02-2024
Profiel
Founder of Acceleron Pharma, Inc., Jasbir S.
Seehra currently is President, Chief Executive Officer & Director at Keros Therapeutics, Inc.
Dr. Seehra previously held the position of Vice President-Biological Chemistry at Wyeth Pharmaceuticals, Inc., Chief Scientific Officer & Senior Vice President at Acceleron Pharma, Inc., Chief Scientific Officer for Ember Therapeutics, Inc., Vice President at Wyeth LLC, Principal at Genetics Institute LLC and Principal at AVEO Pharmaceuticals, Inc.
Jasbir S.
Seehra received a doctorate and an undergraduate degree from The University of Southampton.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
KEROS THERAPEUTICS, INC.
0.76% | 23-02-2024 | 252 856 ( 0.76% ) | 17 M $ | 29-02-2024 |
Actieve functies van Jasbir Seehra
Bedrijven | Functie | Begin |
---|---|---|
KEROS THERAPEUTICS, INC. | Chief Executive Officer | 01-12-2015 |
Eerdere bekende functies van Jasbir Seehra
Bedrijven | Functie | Einde |
---|---|---|
ELOXX PHARMACEUTICALS, INC. | Director/Board Member | 28-06-2022 |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 01-04-2015 |
ACCELERON PHARMA INC. | Founder | 01-11-2010 |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Corporate Officer/Principal | - |
AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Opleiding van Jasbir Seehra
The University of Southampton | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
KEROS THERAPEUTICS, INC. | Health Technology |
ELOXX PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Ember Therapeutics, Inc. /Old/
Ember Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ember Therapeutics, Inc. provides treatment for metabolic disorders and obesity diseases. Its products target brown fat biology and mechanisms of selective insulin sensitization. The company was founded by Bruce M. Spiegelman, Patrick R. Griffin and Ronald C. Kahn in 2011 and is headquartered in New York, NY. | Health Technology |
Wyeth Pharmaceuticals, Inc.
Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Health Technology |